Commission a pharmacy valuation: purpose, records and result
We first establish whether you are considering a purchase, sale or succession. The purpose determines the scope and records needed. Earnings are reviewed for exceptional items, owner dependence and transferable profitability; stock, lease commitments, staffing and investment requirements are assessed separately.
- Annual accounts, current management accounts and earnings changes
- Inventory, assets, lease terms and staffing structure
- Valuation date, transaction scope and intended handover
Deliverables and next steps
You receive a documented valuation with assumptions, adjustments, risks and scenarios. Business value, stock and additional funding needs remain separately identifiable. If a third party requires a formal report, its purpose, format and required standard are agreed before engagement.
Prepare a pharmacy purchase in Germany with valuation, due diligence, financing requirements, operating licence and a structured handover plan. Buy a pharmacy in Germany: valuation and handover →
Prepare a pharmacy sale in Germany: valuation, confidential business records, buyer assessment, succession and an organised handover. Sell a pharmacy in Germany: valuation and succession →
Implement a pharmacy QMS in Germany: review SOPs, document control, training and self-inspections with a practical plan for your team. Pharmacy QMS and quality management in Germany →
Match valuation to its purpose
Purchase, sale, succession and finance require transparent assumptions, risks and scenarios.
- Sustainable earnings
- Location and lease risks
- Inventory and working capital
- Value range and sensitivities
Distinguish valuation methods and deliverables
Forward-looking earnings and cash-flow scenarios form the core assessment. Market and asset evidence are used for plausibility, while inventory, fixed assets and working capital remain visible. The required deliverable—an initial value indication, a detailed decision paper or a formal expert opinion—is agreed before work starts.
- Earnings value and sustainable cash flow
- Market and asset plausibility
- Value indication or detailed report
- Clear boundary to legal, tax and statutory expert work
Agree process, documents and effort before starting
A confidential first discussion defines purpose, valuation date, sites, data room and required depth. Scope, timetable and fee can then be quoted responsibly.
- Purpose and recipients
- Data request and plausibility review
- Analysis, scenarios and value range
- Results discussion and next decisions
Review the business and location
We bring together trading data, prescription mix, footfall, competition, local healthcare environment and lease terms.
- Assess earnings, margin and cost base
- Location, competition and potential analysis
- Review premises, lease and development options
Control finance and risk
Purchase price, working capital, investment and liquidity are evaluated in a realistic start-up and transition scenario.
- Business plan and liquidity forecast
- Structured finance documentation
- Prioritised risks, requirements and open items
Execute the handover
We coordinate due diligence and operational transition alongside legal, tax and finance advisers.
- Licence and transition timeline
- Team and partner communication
- Stable procurement and supply from day one
